PCM
BMY icon

Perritt Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Perritt Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,575
Closed -$387K – 105
2025
Q3 		$387K Buy
8,575
+143
+2% +$6.68K 0.18% 116
2025
Q2 		$390K Sell
8,432
-200
-2% -$9.82K 0.2% 105
2025
Q1 		$527K Sell
8,632
-825
-9% -$48.1K 0.29% 75
2024
Q4 		$535K Buy
9,457
+1,210
+15% +$67.6K 0.28% 86
2024
Q3 		$427K Sell
8,247
-585
-7% -$27.4K 0.22% 107
2024
Q2 		$367K Buy
8,832
+1,285
+17% +$57.5K 0.2% 112
2024
Q1 		$409K Buy
7,547
+283
+4% +$14.4K 0.22% 106
2023
Q4 		$373K Sell
7,264
-1,577
-18% -$82.8K 0.21% 111
2023
Q3 		$513K Hold
8,841
– – 0.3% 90
2023
Q2 		$565K Buy
8,841
+1,600
+22% +$107K 0.31% 83
2023
Q1 		$502K Buy
7,241
+60
+0.8% +$4.23K 0.28% 83
2022
Q4 		$517K Buy
7,181
+101
+1% +$7.62K 0.29% 83
2022
Q3 		$503K Buy
7,080
+125
+2% +$9.07K 0.32% 81
2022
Q2 		$536K Hold
6,955
– – 0.33% 82
2022
Q1 		$508K Buy
6,955
+950
+16% +$63.8K 0.27% 96
2021
Q4 		$374K Buy
6,005
+10
+0.2% +$587 0.19% 127
2021
Q3 		$355K Buy
5,995
+410
+7% +$27K 0.19% 134
2021
Q2 		$373K Buy
5,585
+1,115
+25% +$72.7K 0.19% 136
2021
Q1 		$282K Buy
+4,470
New +$278K 0.15% 152
2018
Q4 		– Sell
-3,370
Closed -$209K – 230
2018
Q3 		$209K Buy
+3,370
New +$200K 0.06% 214
2018
Q2 		– Sell
-5,800
Closed -$301K – 226
2018
Q1 		$301K Sell
5,800
-100
-2% -$6.43K 0.09% 198
2017
Q4 		$362K Buy
5,900
+120
+2% +$7.51K 0.1% 198
2017
Q3 		$368K Hold
5,780
– – 0.1% 200
2017
Q2 		$322K Sell
5,780
-100
-2% -$5.44K 0.08% 200
2017
Q1 		$320K Buy
+5,880
New +$323K 0.08% 202

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Perritt Capital Management's BMY Position: Q4 2025 in Review

Perritt Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 8,575 shares — an estimated $387K sold.

Perritt Capital Management first reported a position in BMY in Q1 2017 and held it in 25 quarters. The position peaked at $565K in Q2 2023. 2,449 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Perritt Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Perritt Capital Management sold 8,575 Bristol-Myers Squibb shares in Q4 2025, an estimated $387K.
  • Perritt Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 25 quarters.
  • Perritt Capital Management's Bristol-Myers Squibb position peaked at $565K in Q2 2023.
  • 2,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.